Post-IPO Debt - Eiger BioPharmaceuticals - Jan 4, 2017 Funding Round Profile - Cointime

Bitcoin $87,738.69 -0.09%
Ethereum $3,233.41 -2.67%
BNB $614.94 -5.37%
Optimism $1.61 -10.51%
Arbitrum $0.61 -7.35%
Solana $207.06 -4.81%
Polygon $0.39 -7.35%
Cosmos $5.10 -8.50%
Avalanche $32.96 -7.09%

Bitcoin $87,738.69 -0.09%
Ethereum $3,233.41 -2.67%
BNB $614.94 -5.37%
Optimism $1.61 -10.51%
Arbitrum $0.61 -7.35%
Solana $207.06 -4.81%
Polygon $0.39 -7.35%
Cosmos $5.10 -8.50%
Avalanche $32.96 -7.09%

Eiger BioPharmaceuticals

company

Funding Round

Post-IPO Debt

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Oxford Finance LLC	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 25, 2009	Series A	$ 8.30M	InterWest Partners,Vivo Capital	Detail
Nov 23, 2015	Debt Financing	$ 6M		Detail
Apr 15, 2011	Series A	$ 14.46M	InterWest Partners,Vivo Capital	Detail
Jan 1, 2007	Seed	0	RA Capital Management	Detail
Apr 29, 2016	Post-IPO Equity	$ 2.99M		Detail
Mar 21, 2016	Debt Financing	0	InterWest Partners	Detail
Mar 23, 2016	IPO	0		Detail